Anxiety, Nausea, Vomiting
Conditions
Brief summary
The overall goal of this study is to explore the effectiveness of using acupuncture versus aromatherapy, in conjunction with standard of care anti-emetics, to decrease chemotherapy induced nausea, vomiting, and anxiety in breast cancer patients undergoing Adriamycin and Cytoxan. This study also aims to determine if aromatherapy and anti-emetics is more effective than acupuncture and anti-emetics in treating nausea, vomiting, and anxiety in patients receiving Adriamycin and Cytoxan and if acupuncture and anti-emetics is more effective than aromatherapy and anti-emetics in treating nausea, vomiting, and anxiety in patients receiving Adriamycin and Cytoxan.
Interventions
Acupuncture is a form of alternative medicine in which thin needles are inserted into the body.
Aromatherapy is a form of alternative medicine in which you will inhale aromatic plant extracts and essential oils.
Sponsors
Study design
Eligibility
Inclusion criteria
i) Inclusion * At least 18 years of age on the day of signing informed consent * Patient has a diagnosis of breast cancer * Patient is planned to start Adriamycin and Cytoxan chemotherapy ii) Exclusion * Patients who are unable to adhere to the protocol or treatment schedule * Patients who have a concurrent illness or take medication that induces nausea independent of chemotherapy * Patients undergoing radiotherapy or hormone therapy during chemotherapy treatments * Patients who have a sensitive and/or poor sense of smell * Patients who are allergic to essential oils, specifically peppermint, ginger, and/or lavender * Patients who are already using essential oils or acupuncture for symptom management and are unwilling to stop while participating in this study * Patients who are afraid of or unwilling to receive acupuncture stimulation * Patients who are allergic to stainless steel needles * Thrombocytopenia (Platelets \< 20,000) * Patients who have received aromatherapy and/or acupuncture treatment within 1 week of starting treatment on this study
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Improvement in Nausea | 45 days | Patients will complete an Edmonton Symptom Assessment Scale. Patients will rate their level of nausea from 0-10 with 10 being the worst possible nausea. Patients will also complete a symptom diary where they will track their level of nausea and how often they are nauseous. Patients will also complete an Anti-Emetic Diary which will track how often they are taking their anti-emetic medications to combat nausea. |
| improvement in anxiety | 45 days | Patients will complete an Edmonton Symptom Assessment Scale. Patients will rate their level of anxiety from 0-10 with 10 being the worst possible anxiety. Patients will also complete a symptom diary where they will track their level of anxiety and how often they are anxious. |
| improvement in vomiting | 45 days | Patients will complete a symptom diary where they will track how often they vomit. Patients will also complete an Anti-Emetic Diary which will track how often they are taking their anti-emetic medications to combat vomiting. |
Countries
United States